Archived publications
We have archived all publications relating to the Prescribed List. You can find these on the National Library of Australia's web archive.
Resources
Prostheses List Advisory Committee (PLAC) Operational Guidelines
These guidelines set out how PLAC will operate to deliver on its Terms of Reference.
Australian Government and the Medical Technology Association of Australia (MTAA) Agreement: High Level Workplan
This workplan describes the work the Government intends to do under the Australian Government and MTAA Agreement (2017 to 2022).
Agreement between the Government and the Medical Technology Association of Australia
This agreement with the Medical Technology Association of Australia (MTAA) supports sponsors and suppliers of medical devices. It runs from 15 October 2017 to 31 January 2022.
Pricing regulation associated with the Prostheses List framework
Australian Government response to the Senate Community Affairs Committee report: Pricing regulation associated with the Prostheses List framework.
Industry Working Group on Private Health Insurance Prostheses Reform: Final Report
This working group examined opportunities for reform of the prostheses and devices arrangements in the private health insurance sector.
Prostheses List Advisory Committee (PLAC) Terms of Reference
This document sets out the purpose, roles, function and composition of PLAC.
Surgical guides and biomodels – Prescribed List post-listing review
We looked at whether surgical guides and biomodels are eligible for listing on the Prescribed List (PL).
Spinal cord stimulators – Prescribed List post-listing review
We are reviewing the comparative clinical and cost-effectiveness of spinal cord stimulators in the Prescribed List (PL).
Urogynaecological mesh devices (mid-urethral slings) – Prescribed List post-listing review
We reviewed the comparative clinical and cost-effectiveness of mid-urethral slings (MUS) on the Prescribed List (PL).
Metal-backed patellae – Prescribed List post-listing review
We reviewed the comparative clinical effectiveness and cost-effectiveness of metal-backed patellae (MBP) in the Prescribed List (PL). We asked if there is evidence to justify MBP having a higher benefit amount than all-polyethylene patellae (APP).
Changes to the Prescribed List publication and distribution process
We invite you to join our webinar on proposed improvements to the Prescribed List publication and distribution process.
General use items on the Prescribed List
Learn about general use items and the history around these items on the Prescribed List.
Reducing the public and private sector price gap for some Prescribed List devices and products
We are reducing the benefits paid for some Prescribed List devices and products to better align with prices paid in the public sector.
Moving Prescribed List applications to the Health Products Portal (HPP)
We are changing the online application system from the Prescribed List Management System to the Health Products Portal. Learn about this change, including key dates.
Modernising the Prescribed List application process
Learn about the work we are doing to modernise the process of applying to have a product included on the Prescribed List.
Improving compliance and assurance for the Prescribed List
Learn about compliance and assurance measures to safeguard the settings of the Prescribed List.
Changes in legislation for the Prescribed List
Learn about legislation changes to the Private Health Insurance Act 2007 and related instruments that will give effect to the Prescribed List Reforms.
Benefit reductions for Cardiac Implantable Electronic Devices
Learn about how we are reducing benefits for Cardiac Implantable Electronic Devices (CIEDs).
Date last updated: